Delivery Order SPE2DB24D2106-SPE2DB25FAWHX
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $7,410 firm fixed-price delivery order by the Defense Logistics Agency on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract calls for the delivery of TYPHIM VI 25 MCG/0.5 ML syringes—a typhoid conjugate vaccine used for immunization purposes—to support Department of Defense healthcare requirements. This delivery order was issued without...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $48,899.74 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a period of performance through September 27, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,520.80 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, with a completion date of July 7, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders...
- This firm fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,040.42 contract is for the supply of 4565900982 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a period of performance through September 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $1,482.00 for Typhoid VI Polysaccharide vaccine. The contract, issued by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 28, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,781.69 for Typhoid VI Polysaccharide vaccine by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract, issued on August 18, 2025, with an ultimate completion date of August 28, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued against DMS...
- DMS Pharmaceutical Group Inc. was awarded a $8,384.20 firm fixed price delivery order by the Defense Logistics Agency to supply 4559552289 TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The delivery order has a period of performance through January 6, 2023. No set-aside provisions were applied to this award. The Defense Logistics Agency supports America's armed forces by procuring their equipment, supplies, and services, including pharmaceutical products. DMS Pharmaceutical Group Inc. will fulfill this...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,854.46, is a delivery order for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,490.61 for Typhoid VI Polysaccharide vaccine on August 11, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, which carries a potential value of $499,999,999 through November 2026. The award carries no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $6,490.61 for Typhoid VI Polysaccharide vaccine, with an ultimate completion date of September 8, 2025. This delivery order was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWHXDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $28,024.56 firm fixed-price delivery order by the Defense Logistics Agency for TYPHIM VI 25 MCG/0.5 ML syringes. The contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed in Conshohocken, Pennsylvania. This delivery order was issued without a set-aside designation and represents a single-product pharmaceutical supply requirement to support Department of Defense healthcare operations. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The SPE2DB program vehicle enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, vaccines, and medical consumables. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering diverse medical products to military health facilities worldwide through this high-value master contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.0k | 9/8/25 |